Bendamustine supercharge plus brentuximab vedotin as early salvage therapy following failure to obtain complete metabolic remission after two cycles of adriamycin-bleomycin-vinblastine-dacarbazine for classic Hodgkin lymphoma in patients aged ≤ 60 years: Long-term efficacy results of a retrospective multicentre study
对于年龄≤60岁的经典型霍奇金淋巴瘤患者，在接受两周期阿霉素-博来霉素-长春碱-达卡巴嗪治疗后未能获得完全代谢缓解的情况下，早期挽救治疗方案为苯达莫司汀超级强化方案联合维布妥昔单抗：一项回顾性多中心研究的长期疗效结果
期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.20053
Giordano, C; Picardi, M; Pugliese, N; Vincenzi, A; Avilia, S; De Fazio, L; Lamagna, M; Reina, R; Scarpa, A; Lombardi, A; Vigliar, E; Troncone, G; Mascolo, M; Mainolfi, C; Fonti, R; Del Vecchio, S; Damiano, V; Bianco, R; Trastulli, F; Annunziata, M; Salemme, A; Carchia, M; Pane, F
